News

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. VANCOUVER BC: APRIL 2, 2024 – EMPOWER CLINICS INC. (CSE:EPW)(OTCQB:EPWCF)  (“Empower” or the “Company”) today announces that the British Columbia Securities Commission (the “BCSC”) has issued an order dated April 2, 2024 (the “Partial Revocation Order”) partially revoking the failure-to-file cease trade order (the “FFCTO”) which was issued against the Company by the BCSC and the Ontario...

EMPOWER CLINICS ANNOUNCES RECEIPT OF CONTRACTS AND BUDGET FOR FIRST CLINICAL TRIAL FROM GLOBAL FORTUNE 500 PHARMACEUTICAL COMPANY AND PROVIDES CORPORATE UPDATE VANCOUVER, B.C.: OCTOBER 23, 2023 – EMPOWER CLINICS INC (CSE:EPW) (PINK:EPWCF) ("Empower" or the "Company") a healthcare company with a developing research and clinical trials division announces its subsidiary EPW Curesearch LLC (“EPWC”) has been awarded its first clinical trial and has received contracts and budget from the trial...